| Financial Year |
March 31 2023 |
| Monetary Funds |
538,260,117.70 |
| Held-for-trading Financial Assets |
927,253,976.92 |
| Notes Receivable |
420,039,666.38 |
| Accounts Receivable |
1,138,303,990.00 |
| Advances to Suppliers |
15,310,856.19 |
| Other Receivables |
35,639,871.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
994,525,676.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,230,030.57 |
| Total Current Assets |
5,011,606,900.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,500,000.00 |
| Long-term Equity Investment |
35,350,478.04 |
| Investment Properties |
35,319,586.33 |
| Fixed Assetes |
1,264,290,665.92 |
| Under-construction Projects |
139,369,652.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
304,039,552.08 |
| R&D expenses |
-- |
| Goodwill |
114,100,834.55 |
| Long-Term Deferred and Prepaid Expenses |
1,479,602.63 |
| Deferred Income Tax Assets |
115,232,859.56 |
| Other Non-Current Assets |
65,330,877.10 |
| Sub-Total of Non-Current Assets |
2,157,948,338.55 |
| Total Assets |
7,169,555,238.98 |
| Short-Term Loans |
38,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,212,265,791.19 |
| Accounts Payable |
1,219,521,596.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
47,599,853.94 |
| Taxes Payable |
24,358,732.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
111,425,493.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,104,839.84 |
| Other Current Liabilities |
309,225.31 |
| Sub-Total of Current Liabilities |
2,800,297,859.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
59,704,654.22 |
| Deferred Income Tax Liabilities |
13,839,685.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
125,125,841.06 |
| Total Liabilities |
2,925,423,700.38 |
| Paid-In Capital(Or Share Stock) |
628,581,600.00 |
| Capital Surplus |
742,383,115.87 |
| Surplus Reserve |
314,290,800.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,122,195,954.61 |
| Minority Stockholder's Interest |
444,580,301.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,799,551,237.31 |
| Owner's Equity（Stockholder's Equity） |
4,244,131,538.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,169,555,238.98 |
